Literature DB >> 2064762

Utilisation of drugs for diabetes mellitus.

H I Feldman1, B L Strom.   

Abstract

This article reviews the data from drug utilisation research on antidiabetic agents, oral hypoglycaemics and insulin. Study methods specific to this type of pharmacoepidemiological research are discussed and critiqued. A brief overview of the sources of drug utilisation data is presented, followed by a review of specific pharmacoepidemiological investigations. We evaluate the usefulness of these studies in assessing true drug consumption, in evaluating comorbidity in diabetic patients and in measuring the prevalence of diabetes. International comparisons of antidiabetic drug utilisation, also reviewed and analysed, demonstrate wide variations in the use of hypoglycaemic agents, which have arisen for reasons which are unclear. Drug utilisation research thus far has been limited by the paucity of studies relating these variations in antidiabetic drug use to specific clinical outcomes. There is a need to expand the applications of research on the use of antidiabetic agents, including assessment of patterns of morbidity across geographic boundaries and over time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064762     DOI: 10.2165/00002018-199106030-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  22 in total

Review 1.  Agreement between questionnaire data and medical records. The evidence for accuracy of recall.

Authors:  S D Harlow; M S Linet
Journal:  Am J Epidemiol       Date:  1989-02       Impact factor: 4.897

2.  Drug utilization study methodologies: national and international perspectives.

Authors:  J Serradell; D C Bjornson; A G Hartzema
Journal:  Drug Intell Clin Pharm       Date:  1987-12

3.  Drug sales data and prevalence of diabetes in France.

Authors:  A Fontbonne; L Papoz; E Eschwege
Journal:  Rev Epidemiol Sante Publique       Date:  1986       Impact factor: 1.019

4.  Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden.

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; P K Lunde; U Bergman; A Wessling; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Utilization of antidiabetic drugs in the Island of Gotland, Sweden: agreement between wholesale figures and prescription data.

Authors:  U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

6.  The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.

Authors:  U Bergman; P Elmes; M Halse; T Halvorsen; H Hood; P K Lunde; F Sjöqvist; O L Wade; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

7.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Diabetes mellitus in an urbanized, isolated Polynesian population. The Funafuti survey.

Authors:  P Zimmet; A Seluka; J Collins; P Currie; J Wicking; W DeBoer
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

9.  A pharmaceutical profile of diabetic patients.

Authors:  M Rendell; W D Lassek; D A Ross; C Smith; S Kernek; J Williams; M Brown; L Willingmyre; L Yamamoto
Journal:  J Chronic Dis       Date:  1983
View more
  4 in total

1.  Sleep quality in residents of assisted living facilities: effect on quality of life, functional status, and depression.

Authors:  Jennifer L Martin; Lavinia Fiorentino; Stella Jouldjian; Karen R Josephson; Cathy A Alessi
Journal:  J Am Geriatr Soc       Date:  2010-05       Impact factor: 5.562

2.  Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels.

Authors:  A Melander; P Folino-Gallo; T Walley; U Schwabe; P-H Groop; T Klaukka; A Vallano; J-R Laporte; M R Gallego; M Schiappa; M Røder; J P Kampmann; A de Swaef; M Aberg; N-O Månsson; U Lindblad
Journal:  Diabetologia       Date:  2006-07-25       Impact factor: 10.122

3.  Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines.

Authors:  Pia Frisk; Tor-Olov Mellgren; Niklas Hedberg; Anita Berlin; Fredrik Granath; Björn Wettermark
Journal:  Eur J Clin Pharmacol       Date:  2008-08-15       Impact factor: 2.953

4.  The use of hypoglycaemic and cardiovascular drugs in 582 patients with diabetes mellitus. Description and quality assessment.

Authors:  G Van den Brink; R R Schwartzenberg; L J Hoeve; A J Porsius; L L Hoeve
Journal:  Pharm World Sci       Date:  1993-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.